CIM-0216 is a selective TRPM3 agonist. References: Held K, Gruss F, Aloi VD, Janssens A, Ulens C, Voets T, Vriens J. Mutations in the voltage-sensing domain affect the alternative ion permeation pathway in the TRPM3 channel. J Physiol. 2018 Jun;596(12):2413-2432. doi: 10.1113/JP274124. Epub 2018 Apr 25. PubMed PMID: 29604058; PubMed Central PMCID: PMC6002228.

纯度：≥98%

CAS：1031496-06-6